FDA Inspection 972742 — Stephen C. Jensik

Stephen C. Jensik — FEI 3012327274

The FDA completed an inspection of Stephen C. Jensik on June 9, 2016 in Chicago, IL. The inspection was classified OAI (Official Action Indicated — objectionable conditions were found and regulatory action is recommended). 2 citations were issued during this inspection. Product area: Biologics.

Inspection Details

Classification
Official Action Indicated (OAI) (OAI)
End Date
June 9, 2016
Fiscal Year
2016
Product Type
Biologics
Project Area
Bioresearch Monitoring
Location
Chicago, IL (United States)

Additional Details

Clinical Investigator (CI)

Citations

IDCFRDescription
753021 CFR 312.62(b)Case history records- inadequate or inadequate
753121 CFR 312.62(c)Record retention